Y Intercept (Hong Kong) LTD Neogenomics Inc Transaction History

Y Intercept (Hong Kong) LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$11.67 - $20.73 $332,128 - $589,975	28,460 Added 282.9%	38,520 $623,000
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $122,229 - $179,571	10,060 New	10,060 $123,000
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $190,100 - $355,739	29,473 Added 205.92%	43,786 $404,000
Q3 2022 Feb 14, 2023	BUY	$7.86 - $12.91 $112,500 - $184,780	14,313 New	14,313 $123,000
Q2 2022 Aug 08, 2022	SELL	$7.06 - $13.97 $408,978 - $809,268	-57,929 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $703,837 - $2.04 Million	57,929 New	57,929 $704,000
Q2 2021 Aug 12, 2021	SELL	$36.62 - $51.69 $252,861 - $356,919	-6,905 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$41.56 - $59.88 $286,971 - $413,471	6,905 New	6,905 $309,000

291

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.82B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.